Estrogen Therapy and PCT Risk
Estrogen therapy was associated with increased porphyria cutanea tarda risk, with oral administration showing the strongest association.
Estrogen therapy was associated with increased porphyria cutanea tarda risk, with oral administration showing the strongest association.